跳至主要内容
临床试验/NCT00433771
NCT00433771已完成3 期

A Multi-Center, Single Arm, Prospective Study of the WallFlex™ Biliary Fully-covered Stent for the Palliative Treatment of Malignant Bile Duct Obstruction

Boston Scientific Corporation10 个研究点 分布在 1 个国家目标入组 74 人开始时间: 2007年3月1日最近更新:
适应症
干预措施

试验速览

阶段
3 期
状态
已完成
入组人数
74
试验地点
10
主要终点
Adequate Clinical Palliation of the Biliary Obstruction

研究概览

简要总结

The overall objective of this study is to assess the functionality of the WallFlex™ Biliary Fully-covered stent as a palliative treatment for malignant bile duct obstruction.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Age 18 or older
  • •Clinical symptoms of biliary obstruction
  • •Inoperable extrahepatic biliary obstruction by any malignant process
  • •Willing and able to comply with the study procedures and provide written informed consent to participate in the study.

排除标准

  • •Participation in an Investigational Study within 90 days prior to date of patient consent
  • •Strictures that cannot be dilated enough to pass the delivery system
  • •Perforation of any duct within the biliary tree
  • •Presence of a metal biliary stent
  • •Presence of any esophageal or duodenal stent
  • •Patients for whom endoscopic procedures are contraindicated
  • •Patients with known sensitivity to any components of the stent or delivery system
  • •Patients with active hepatitis or intrahepatic metastases that extensively involves both lobes of the liver
  • •Patients with an anticipated life expectancy of < 3 months

研究组 & 干预措施

WallFlex Biliary Fully Covered stent

Experimental

Single arm, biliary stenting, using WallFlex Biliary Fully Covered stent

干预措施: WallFlex™ Biliary Fully Covered Metal Stent placement (Device)

结局指标

主要结局

Adequate Clinical Palliation of the Biliary Obstruction

时间窗: 6 months

Adequate clinical palliation of the biliary obstruction as demonstrated by the absence of stent occlusion within 6 month follow up or prior to death, whichever comes first in the evaluable subject cohort of 55 patients.

次要结局

  • Technical Success(At treatment)
  • Ability to Successfully Remove a Stent Upon Removal Attempt(6 months)
  • Re-interventions(Until 6 months or death)
  • Clinical Success at 1 Month After Stent Procedure as Defined by Reduction of Biliary Obstruction Symptoms(1 Month)
  • Clinical Success at 3 Months After Stent Procedure as Defined by the Reduction of Biliary Obstruction Symptoms(3 months)
  • Clinical Success at 6 Months After Stent Procedure as Defined by the Reduction of Biliary Obstruction Symptoms(6 months)
  • Bilirubin Level Reduction(1 month)
  • Stent Patency at 1 Month(1 month)
  • Stent Patency at 3 Months(3 Months)
  • Stent Patency at 6 Months(6 Months)
  • Time to Stent Occlusion(Until 6 Months or death)
  • Number of Device-Related Adverse Events(Until 6 months or death)

研究者

申办方类型
Industry

研究点 (10)

Loading locations...

相似试验

A Study of the WallFlex™ Biliary Fully-covered Stent... | 临床试验